Unique/Major Human Metabolites: Why, How, and When to Test for Safety in Animals

ISSN： 0360-2532

Source： Drug Metabolism Reviews, Vol.40, Iss.3, 2008-07, pp. : 447-463

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prediction of warfarin dose: why, when and how?

By Eriksson Niclas Wadelius Mia

Pharmacogenomics, Vol. 13, Iss. 4, 2012-03 ,pp. : 429-440

Future Medicine

Access to resources Recommend Favorite

Addressing MIST (Metabolites in Safety Testing): Bioanalytical Approaches to Address Metabolite Exposures in Humans and Animals

Current Drug Metabolism, Vol. 12, Iss. 6, 2011-07 ,pp. : 578-586

Bentham Science Publishers

Access to resources Recommend Favorite

Gamma-Secretase as a Pharmacological Target in Alzheimer Disease Research: When, Why and How?

Current Pharmaceutical Design, Vol. 12, Iss. 33, 2006-11 ,pp. : 4313-4335

Bentham Science Publishers

Access to resources Recommend Favorite

Fractalkine/CX3CR1: why a single chemokine-receptor duo bears a major and unique therapeutic potential

By D'Haese Jan G Demir Ihsan Ekin Friess Helmut Ceyhan Güralp O

Expert Opinion on Therapeutic Targets, Vol. 14, Iss. 2, 2010-02 ,pp. : 207-219

Informa Healthcare

Access to resources Recommend Favorite

NO to Breast: When, Why and Why Not?

Current Pharmaceutical Design, Vol. 16, Iss. 4, 2010-02 ,pp. : 451-462

Bentham Science Publishers

Access to resources Recommend Favorite